Laurie Toich, Assistant Editor

Calquence is a kinase inhibitor that blocks an enzyme crucial for cancer growth.

Acalabrutinib (Calquence) found to improve overall response rate among patients with mantle cell lymphoma.

Consuming soy-based products may not be as beneficial for heart health as previously thought.

Ozanimod may slow multiple sclerosis progression more than first-line therapy.

Integration of social services into hospital care could connect patients with necessary services.

Bevacizumab (Avastin) may improve progression-free survival among treatment-naïve patients with ovarian cancer.

High levels of exercise may not have a significant impact on the development of heart disease.

A byproduct of cholesterol metabolism may fuel the spread of solid tumors.

Novel biologics are able to control ulcerative colitis symptoms and prevent surgical intervention.

Top news of the day from across the healthcare landscape.

Pharmacy wholesaler stocks dropped significantly due to concerns over retail giant Amazon entering the pharmacy space.

Only one-quarter of patients prescribed opioids discussed the potential of addiction with their provider.

Exposure to many chemicals, including gasoline, can heighten the risk of developing breast cancer.

New network encourages medication adherence for chronic conditions.

New discovery about EGFR signaling may prevent cancer cells from spreading.

Pregnant women who slept less than 6.5 hours per night were nearly 3 times as likely to develop gestational diabetes.

Top news of the day from across the healthcare landscape.

Top news of the day from across the healthcare landscape.

Analysis shows that more engaged employers work diligently with their pharmacy benefit managers to assure alignment between services and total value.

Employers provide coverage for 56% of the insured population, which carries significant weight with pharmacy benefit managers.

Market instability contributes to increasing premiums for 2018 Affordable Care Act health plans.

Combination therapy found to reverse multiple sclerosis in mice models.

Deleting fatty acid-binding proteins may lead to lifelong metabolic health.

Top news of the day from across the healthcare landscape.

Top news of the day from across the healthcare landscape.

The emergence of biosimilars will reduce spending on biologics by 3% through 2027.

Drugs administered in an outpatient setting may be marked-up more than 500%.

Genome analysis points to potential new treatments for patients with chordoma.

Atrial fibrillation risk increases in men a decade before women.

Novel drug causes apoptosis in leukemia cells, while leaving healthy blood cells unscathed.